Literature DB >> 21547462

Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).

Ulrich Müller1.   

Abstract

Paragangliomas/pheochromocytomas (PGL/PCC) are tumors of the paraganglia. They can occur sporadically, as one sign in a hereditary (tumor) syndrome or as the only manifestation in hereditary PGL/PCC. To date, five forms of hereditary PGL/PCC have been described. They are inherited as autosomal dominant traits and are caused by mutations in genes required for structure and function of complex II of the respiratory chain (succinate-ubiquinone oxidoreductase, succinate dehydrogenase, SDH). Mutations in genes encoding the small subunits of SDH, i.e., SDHD and SDHC, cause PGL1 and PGL3. Mutations in the large subunit genes SDHB, SDHA (currently only one case), and in SDHAF2 cause PGL4, 5, and 2, respectively. This article gives an overview of PGL/PCC in the context of the anatomy and function of paraganglia. It describes SDH, the genes encoding SDH, and provides information on genetic mechanisms in hereditary PGL/PCC. A model is proposed to explain exclusive paternal inheritance and loss of the maternal (putatively imprinted) allele as a prerequisite for tumor formation in PGLs 1 and 2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547462     DOI: 10.1007/s10048-011-0280-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  40 in total

1.  Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30-year-old mystery.

Authors:  R Neil Schimke; Debra L Collins; Catherine A Stolle
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

2.  Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance.

Authors:  J Arias-Stella; J Valcarcel
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

3.  High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.

Authors:  E F Hensen; N van Duinen; J C Jansen; E P M Corssmit; C M J Tops; J A Romijn; A H J T Vriends; A G L van der Mey; C J Cornelisse; P Devilee; J P Bayley
Journal:  Clin Genet       Date:  2011-03-15       Impact factor: 4.438

4.  Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.

Authors:  Sungwoo Lee; Eijiro Nakamura; Haifeng Yang; Wenyi Wei; Michelle S Linggi; Mini P Sajan; Robert V Farese; Robert S Freeman; Bruce D Carter; William G Kaelin; Susanne Schlisio
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

Review 5.  Carotid body chemoreceptors: from natural stimuli to sensory discharges.

Authors:  C Gonzalez; L Almaraz; A Obeso; R Rigual
Journal:  Physiol Rev       Date:  1994-10       Impact factor: 37.312

Review 6.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.

Authors:  Diana E Benn; Michael S Croxson; Kathy Tucker; Christopher P Bambach; Anne Louise Richardson; Leigh Delbridge; Peter T Pullan; Jeremy Hammond; Deborah J Marsh; Bruce G Robinson
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

8.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

9.  SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.

Authors:  Huai-Xiang Hao; Oleh Khalimonchuk; Margit Schraders; Noah Dephoure; Jean-Pierre Bayley; Henricus Kunst; Peter Devilee; Cor W R J Cremers; Joshua D Schiffman; Brandon G Bentz; Steven P Gygi; Dennis R Winge; Hannie Kremer; Jared Rutter
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

10.  No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.

Authors:  Katie T Huang; Alexander Dobrovic; Stephen B Fox
Journal:  BMC Res Notes       Date:  2009-09-25
View more
  7 in total

Review 1.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

2.  Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.

Authors:  K J Johnson; M J Fisher; R L Listernick; K N North; E K Schorry; D Viskochil; M Weinstein; J B Rubin; D H Gutmann
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

3.  Differential impairment of catecholaminergic cell maturation and survival by genetic mitochondrial complex II dysfunction.

Authors:  Blanca Díaz-Castro; C Oscar Pintado; Paula García-Flores; José López-Barneo; José I Piruat
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

5.  Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeast.

Authors:  Ya-Lan Chang; Meng-Hsun Hsieh; Wei-Wen Chang; Hurng-Yi Wang; Mei-Chun Lin; Cheng-Ping Wang; Pei-Jen Lou; Shu-Chun Teng
Journal:  Antioxid Redox Signal       Date:  2015-01-13       Impact factor: 8.401

Review 6.  The epigenetic-metabolic interplay in gliomagenesis.

Authors:  Bismi Phasaludeen; Bright Starling Emerald; Suraiya Anjum Ansari
Journal:  Open Biol       Date:  2022-04-06       Impact factor: 6.411

Review 7.  Succinate: An initiator in tumorigenesis and progression.

Authors:  Ting Zhao; Xianmin Mu; Qiang You
Journal:  Oncotarget       Date:  2017-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.